Symptom assessment tool for overactive bladder syndrome- Overactive bladder symptom score
Symptom assessment tool for overactive bladder syndrome- Overactive bladder symptom score
复制标题
DOI：
10.1016/j.urology.2006.02.042
复制
发表时间：
2006-08-01
期刊：
影响因子：
2.1
通讯作者：
Nishizawa, Osamu
中科院分区：
文献类型：
--
作者：
Homma, Yukio;Yoshida, Masaki;Nishizawa, Osamu
目标。膀胱过动症（OAB）是一种常见的急症、尿频和急迫性尿失禁症状。为了共同表达膀胱过动症症状，我们制定了膀胱过动症评分（OABSS）。对四种症状——白天频率、夜间频率、尿急和尿急失禁进行评分。称重评分是基于对流行病学数据库的二次分析。对五组患者进行心理测量：OAB组（83例）、无症状对照组（34例）、应激性尿失禁组（29例）、良性前列腺增生组（28例）和其他有泌尿系统症状的疾病组（26例）。日间尿频、夜间尿频、尿急和尿急失禁的最高评分分别为2、3、5和5。OAB患者的OABSS总评分（0 ~ 15）为8.36，明显高于其他患者组（1.82 ~ 5.14）。OABSS的分布在OAB患者和无症状对照组之间有明显的分离。OABSS与个人得分（Spearman's r = 0.10至0.78）和King's健康问卷评估的生活质量得分（Spearman's r = 0.20至0.49）呈正相关。各症状评分的加权kappa系数为0.804 ~ 1.0，OABSS的加权kappa系数为0.861。治疗后OABSS的降低与患者对治疗效果的总体印象一致。OABSS是四种症状（白天尿频、夜间尿频、尿急和尿急失禁）的总评分，已被开发和验证。OABSS可能是研究和临床实践的有用工具。
Objectives. Overactive bladder (OAB) is a common symptom syndrome with urgency, urinary frequency, and urgency incontinence. To collectively express OAB symptoms, we developed the overactive bladder symptom score (OABSS).Methods. Four symptoms-daytime frequency, nighttime frequency, urgency, and urgency incontinence-were scored. The weighing score was based on a secondary analysis of an epidemiologic database. Psychometric properties were examined in five patient groups: OAB (n = 83), asymptomatic controls (n = 34), stress incontinence (n = 29), benign prostatic hyperplasia (n = 28), and other diseases with urinary symptoms (n = 26).Results. The maximal score was defined as 2, 3, 5, and 5 for daytime frequency, nighttime frequency, urgency, and urgency incontinence, respectively. The sum score (OABSS 0 to 15) was significantly greater in the patients with OAB (8.36) than in the other patient groups (1.82 to 5.14). The distribution of the OABSS showed a clear separation between those with OAB and asymptomatic controls. The OABSS correlated positively with the individual scores (Spearman's r = 0.10 to 0.78) and quality-of-life scores assessed by the King's Health Questionnaire (Spearman's r = 0.20 to 0.49). The weighted kappa coefficients were 0.804 to 1.0 for each symptom score and 0.861 for OABSS. The posttreatment reduction in the OABSS was consistent with the global impression of patients of the therapeutic efficacy.Conclusions. The OABSS, the sum score of four symptoms (daytime frequency, nighttime frequency, urgency, and urgency incontinence), has been developed and validated. OABSS may be a useful tool for research and clinical practice.